Advanced Search

 

Study ID Status Title Patient Level Data
205638 Withdrawn An open-label, multicenter, randomized, parallel group, single-dose study to assess the short term efficacy and safety of paracetamol 500 mg + phenylephrine HCl 10 mg + vitamin C 200 mg powder for oral solution in subjects with symptoms of an upper respiratory tract infection
205639 Recruiting Meta-analysis of the risk of autoimmune thyroiditis diseases, Guillain-Barré Syndrome, and Inflammatory Bowel Disease with Cervarix Vaccination
205643 Completed PGx7654: Pharmacogenetic investigation of the association of the beta2-adrenergic receptor (ADRB2) Thr164Ile variant with risk of hospitalization due to asthma exacerbations
205646 Not yet recruiting A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination with Rituximab to Adult Subjects with Systemic Lupus Erythematosus (SLE)
205653 Active, not recruiting Relvar 100 Ellipta Special Drug Use Investigation (COPD, Long-term)
205654 Not yet recruiting MALARONE Pediatric Combination Tablets Special Drug Use Investigation
205665 Recruiting A randomized, open-label study to evaluate the effect of daprodustat on blood pressure in subjects with anemia associated with chronic kidney disease on hemodialysis switched from a stable dose of an erythropoiesis-stimulating agent
205667 Completed An open-label, single arm, repeat dose, multi-centre study to evaluate the use of a safety syringe for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study 205667)
205670 Recruiting A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
205684 Completed A Randomized, Parallel-Group, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Subjects with Symptoms of Common Cold
205687 Recruiting A randomised, double-blind, parallel group PhIII study to assess the clinical efficacy and safety of 100 mg SC Mepolizumab as an add on to maintenance treatment in adults with severe bilateral nasal polyps
205689 Terminated Effects of cold and/or flu on motivation, mood and cognitive performance in otherwise healthy individuals
205694 Completed An open-label, randomized, single-dose, two-period cross-over study to evaluate bioequivalence of GSK3542503 hydrochlorothiazide + amiloride hydrochloride 50 mg: 5 mg fixed dose combination tablets versus reference product in healthy adult participants under fasting conditions
205697 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205698 Enrolling by invitation Qualitative Research in Patients with Systemic Amyloidosis: Interviews on Symptoms and Impact of Disease
205699 Completed Assessment of Dentine Tubule Occlusion in a Modified in situ Model
205703 Recruiting A study to evaluate potential biomarkers of muscular dystrophy
205707 Active, not recruiting Post-Marketing Observational Study to Evaluate Safety Profile of Avamys Treatment in Chinese Patients
205708 Active, not recruiting Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray
205710 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205715 Recruiting A Phase III, randomized, double-blind, active controlled, parallel group study, comparing the efficacy, safety and tolerability of the fixed dose combination FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled asthma
205717 Recruiting Volibris® Tablets 2.5 mg Special Drug Use Investigation (Post-marketing survey in Japan)
205722 Recruiting A randomised double-blind (sponsor open), placebo controlled, single ascending dose, First Time in Human study in participants with mild to moderate asthma to assess safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of GSK3511294 administered subcutaneously
205724 Recruiting Randomised, Double-Blind (Sponsor Open), Placebo-Controlled, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of Danirixin Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
205730 Completed An open-label, randomised, single-dose, two-period cross-over study to evaluate bioequivalence of GR37547 ciprofloxacin 500 mg tablet versus ciprofloxacin 500 mg tablet reference product in healthy adult participants under fasting conditions

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.